CG Oncology Aims To Raise Up To $212M As It Sets IPO Terms
Bladder-cancer therapy company CG Oncology set terms for its planned initial public offering Thursday, saying it intends to offer 11.8 million shares for between $16 and $18 per share, meaning it could...To view the full article, register now.
Already a subscriber? Click here to view full article